370 related articles for article (PubMed ID: 26881932)
1. MT1-MMP Activation of TGF-β Signaling Enables Intercellular Activation of an Epithelial-mesenchymal Transition Program in Cancer.
Nguyen HL; Kadam P; Helkin A; Cao K; Wu S; Samara GJ; Zhang Q; Zucker S; Cao J
Curr Cancer Drug Targets; 2016; 16(7):618-30. PubMed ID: 26881932
[TBL] [Abstract][Full Text] [Related]
2. MT1-MMP Cooperates with TGF-β Receptor-Mediated Signaling to Trigger SNAIL and Induce Epithelial-to-Mesenchymal-like Transition in U87 Glioblastoma Cells.
Djediai S; Gonzalez Suarez N; El Cheikh-Hussein L; Rodriguez Torres S; Gresseau L; Dhayne S; Joly-Lopez Z; Annabi B
Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884812
[TBL] [Abstract][Full Text] [Related]
3. Membrane type 1-matrix metalloproteinase induces epithelial-to-mesenchymal transition in esophageal squamous cell carcinoma: Observations from clinical and in vitro analyses.
Pang L; Li Q; Li S; He J; Cao W; Lan J; Sun B; Zou H; Wang C; Liu R; Wei C; Wei Y; Qi Y; Hu J; Liang W; Zhang WJ; Wan M; Li F
Sci Rep; 2016 Feb; 6():22179. PubMed ID: 26916665
[TBL] [Abstract][Full Text] [Related]
4. Membrane Type 1 Matrix Metalloproteinase induces an epithelial to mesenchymal transition and cancer stem cell-like properties in SCC9 cells.
Yang CC; Zhu LF; Xu XH; Ning TY; Ye JH; Liu LK
BMC Cancer; 2013 Apr; 13():171. PubMed ID: 23548172
[TBL] [Abstract][Full Text] [Related]
5. The metastasis suppressor CD82/KAI1 represses the TGF-β
Lee MS; Lee J; Kim YM; Lee H
Prostate; 2019 Sep; 79(12):1400-1411. PubMed ID: 31212375
[TBL] [Abstract][Full Text] [Related]
6. Transforming growth factor-beta induces CD44 cleavage that promotes migration of MDA-MB-435s cells through the up-regulation of membrane type 1-matrix metalloproteinase.
Kuo YC; Su CH; Liu CY; Chen TH; Chen CP; Wang HS
Int J Cancer; 2009 Jun; 124(11):2568-76. PubMed ID: 19243022
[TBL] [Abstract][Full Text] [Related]
7. Critical roles of Wnt5a-Ror2 signaling in aggressiveness of tongue squamous cell carcinoma and production of matrix metalloproteinase-2 via ΔNp63β-mediated epithelial-mesenchymal transition.
Sakamoto T; Kawano S; Matsubara R; Goto Y; Jinno T; Maruse Y; Kaneko N; Hashiguchi Y; Hattori T; Tanaka S; Kitamura R; Kiyoshima T; Nakamura S
Oral Oncol; 2017 Jun; 69():15-25. PubMed ID: 28559016
[TBL] [Abstract][Full Text] [Related]
8. Less is more: low expression of MT1-MMP is optimal to promote migration and tumourigenesis of breast cancer cells.
Cepeda MA; Pelling JJ; Evered CL; Williams KC; Freedman Z; Stan I; Willson JA; Leong HS; Damjanovski S
Mol Cancer; 2016 Oct; 15(1):65. PubMed ID: 27756325
[TBL] [Abstract][Full Text] [Related]
9. Decreased MT1-MMP in gastric cancer suppressed cell migration and invasion via regulating MMPs and EMT.
Li W; Li S; Deng L; Yang S; Li M; Long S; Chen S; Lin F; Xiao L
Tumour Biol; 2015 Sep; 36(9):6883-9. PubMed ID: 25851348
[TBL] [Abstract][Full Text] [Related]
10. WNT5A signaling impairs breast cancer cell migration and invasion via mechanisms independent of the epithelial-mesenchymal transition.
Prasad CP; Chaurasiya SK; Guilmain W; Andersson T
J Exp Clin Cancer Res; 2016 Sep; 35(1):144. PubMed ID: 27623766
[TBL] [Abstract][Full Text] [Related]
11. Induction of a MT1-MMP and MT2-MMP-dependent basement membrane transmigration program in cancer cells by Snail1.
Ota I; Li XY; Hu Y; Weiss SJ
Proc Natl Acad Sci U S A; 2009 Dec; 106(48):20318-23. PubMed ID: 19915148
[TBL] [Abstract][Full Text] [Related]
12. Epilysin (MMP-28) induces TGF-beta mediated epithelial to mesenchymal transition in lung carcinoma cells.
Illman SA; Lehti K; Keski-Oja J; Lohi J
J Cell Sci; 2006 Sep; 119(Pt 18):3856-65. PubMed ID: 16940349
[TBL] [Abstract][Full Text] [Related]
13. Tumor cell invasion of collagen matrices requires coordinate lipid agonist-induced G-protein and membrane-type matrix metalloproteinase-1-dependent signaling.
Fisher KE; Pop A; Koh W; Anthis NJ; Saunders WB; Davis GE
Mol Cancer; 2006 Dec; 5():69. PubMed ID: 17156449
[TBL] [Abstract][Full Text] [Related]
14. Genistein suppressed epithelial-mesenchymal transition and migration efficacies of BG-1 ovarian cancer cells activated by estrogenic chemicals via estrogen receptor pathway and downregulation of TGF-β signaling pathway.
Kim YS; Choi KC; Hwang KA
Phytomedicine; 2015 Oct; 22(11):993-9. PubMed ID: 26407941
[TBL] [Abstract][Full Text] [Related]
15. PRRX2 as a novel TGF-β-induced factor enhances invasion and migration in mammary epithelial cell and correlates with poor prognosis in breast cancer.
Juang YL; Jeng YM; Chen CL; Lien HC
Mol Carcinog; 2016 Dec; 55(12):2247-2259. PubMed ID: 26824226
[TBL] [Abstract][Full Text] [Related]
16. The tetraspanin CD81 protein increases melanoma cell motility by up-regulating metalloproteinase MT1-MMP expression through the pro-oncogenic Akt-dependent Sp1 activation signaling pathways.
Hong IK; Byun HJ; Lee J; Jin YJ; Wang SJ; Jeoung DI; Kim YM; Lee H
J Biol Chem; 2014 May; 289(22):15691-704. PubMed ID: 24733393
[TBL] [Abstract][Full Text] [Related]
17. SCUBE3 is an endogenous TGF-β receptor ligand and regulates the epithelial-mesenchymal transition in lung cancer.
Wu YY; Peck K; Chang YL; Pan SH; Cheng YF; Lin JC; Yang RB; Hong TM; Yang PC
Oncogene; 2011 Aug; 30(34):3682-93. PubMed ID: 21441952
[TBL] [Abstract][Full Text] [Related]
18. Role of SIRT1 in regulation of epithelial-to-mesenchymal transition in oral squamous cell carcinoma metastasis.
Chen IC; Chiang WF; Huang HH; Chen PF; Shen YY; Chiang HC
Mol Cancer; 2014 Nov; 13():254. PubMed ID: 25424420
[TBL] [Abstract][Full Text] [Related]
19. Pancreatic cancer cells respond to type I collagen by inducing snail expression to promote membrane type 1 matrix metalloproteinase-dependent collagen invasion.
Shields MA; Dangi-Garimella S; Krantz SB; Bentrem DJ; Munshi HG
J Biol Chem; 2011 Mar; 286(12):10495-504. PubMed ID: 21288898
[TBL] [Abstract][Full Text] [Related]
20. Combined treatment with zingerone and its novel derivative synergistically inhibits TGF-β1 induced epithelial-mesenchymal transition, migration and invasion of human hepatocellular carcinoma cells.
Kim YJ; Jeon Y; Kim T; Lim WC; Ham J; Park YN; Kim TJ; Ko H
Bioorg Med Chem Lett; 2017 Feb; 27(4):1081-1088. PubMed ID: 28110870
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
